John F DiPersio Selected Research

Hematopoietic Stem Cell Mobilization

10/2019	A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma.
12/2017	Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.
8/2011	Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.
7/2010	Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
10/2009	Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John F DiPersio Research Topics

Disease

48	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2003
43	Neoplasms (Cancer) 01/2022 - 07/2002
28	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 04/2003
24	Leukemia 01/2022 - 07/2002
23	Multiple Myeloma 01/2022 - 03/2004
18	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2003
17	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 07/2006
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 03/2004
7	Infections 01/2022 - 04/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 04/2008
6	Disease Progression 09/2018 - 02/2010
6	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 03/2012
5	Lymphoma (Lymphomas) 11/2020 - 10/2006
5	Acute Promyelocytic Leukemia 01/2019 - 07/2002
4	Bronchiolitis Obliterans Syndrome 01/2022 - 04/2017
4	Injection Site Reaction 12/2013 - 06/2009
3	Inflammation (Inflammations) 01/2022 - 10/2020
3	Cytokine Release Syndrome 11/2021 - 10/2016
3	Thrombocytopenia (Thrombopenia) 01/2020 - 03/2012
3	Diarrhea 01/2017 - 04/2003
3	Splenomegaly 01/2017 - 02/2014
3	Residual Neoplasm 01/2017 - 07/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2014 - 11/2003
2	Hematologic Diseases (Blood Diseases) 01/2022 - 12/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019 - 12/2019
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
2	Myeloid Leukemia (Leukemia, Myelocytic) 04/2017 - 01/2014
2	Fatigue 01/2017 - 12/2013
2	Chromosome Aberrations (Chromosome Abnormalities) 11/2016 - 02/2015
2	Viremia 11/2016 - 03/2003
2	Anemia 04/2015 - 03/2012
2	Mucositis 01/2014 - 04/2003
1	COVID-19 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Cytopenia 11/2021

Drug/Important Bio-Agent (IBA)

16	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 03/2003
16	plerixafor FDA Link 01/2021 - 03/2004
10	ruxolitinibIBA 01/2022 - 03/2012
8	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 07/2006
7	Decitabine FDA Link 01/2022 - 02/2010
6	Pharmaceutical PreparationsIBA 10/2021 - 03/2012
6	DNA (Deoxyribonucleic Acid)IBA 12/2014 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
4	CytokinesIBA 01/2022 - 11/2020
4	Janus KinasesIBA 01/2022 - 03/2012
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2012
3	SteroidsIBA 01/2022 - 01/2016
3	Azacitidine (5 Azacytidine)FDA Link 11/2021 - 01/2017
3	Bortezomib (Velcade)FDA Link 11/2020 - 11/2007
3	tisagenlecleucelIBA 12/2019 - 01/2019
3	Lenalidomide (CC 5013)FDA Link 01/2018 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2012 - 04/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 09/2010
2	ALT-803IBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Interleukin-15 (Interleukin 15)IBA 01/2022 - 11/2020
2	baricitinibIBA 12/2021 - 11/2018
2	IntegrinsIBA 11/2020 - 04/2016
2	Filgrastim (Neupogen)FDA Link 01/2020 - 12/2017
2	Cladribine FDA LinkGeneric 01/2020 - 08/2009
2	Rituximab (Mabthera)FDA Link 12/2019 - 01/2018
2	Interferon gamma ReceptorIBA 11/2018 - 01/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 08/2017
2	RadiopharmaceuticalsIBA 01/2018 - 04/2016
2	AntibodiesIBA 04/2016 - 01/2016
2	Phosphotransferases (Kinase)IBA 06/2015 - 05/2008
2	Ganciclovir (Cytovene)FDA LinkGeneric 06/2015 - 07/2003
2	Janus Kinase 1IBA 04/2015 - 12/2013
2	Janus Kinase InhibitorsIBA 02/2014 - 05/2013
2	Vorinostat FDA Link 01/2014 - 10/2009
2	Complement System Proteins (Complement)IBA 09/2009 - 08/2009
2	Imatinib Mesylate (Gleevec)FDA Link 04/2008 - 11/2003
2	Cathepsin GIBA 09/2003 - 07/2002
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	VaccinesIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	PhytohemagglutininsIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	efineptakin alfaIBA 01/2022
1	heparanaseIBA 01/2022
1	roneparstatIBA 01/2022
1	AnticoagulantsIBA 01/2022

Therapy/Procedure

43	Therapeutics 01/2022 - 07/2002
25	Cell Transplantation 01/2022 - 01/2014
23	Drug Therapy (Chemotherapy) 12/2021 - 07/2002
17	Immunotherapy 01/2022 - 08/2017
17	Transplantation 01/2022 - 03/2003
14	Hematopoietic Stem Cell Transplantation 12/2018 - 10/2006
10	Stem Cell Transplantation 01/2018 - 07/2004
5	Hematopoietic Stem Cell Mobilization 10/2019 - 10/2009
3	Homologous Transplantation 12/2018 - 07/2006
2	Organ Transplantation 12/2021 - 01/2020
2	Blood Component Removal (Apheresis) 11/2019 - 10/2009
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2012 - 03/2003
2	Autologous Transplantation 07/2011 - 11/2007
1	Drug Tapering 11/2021